Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
7401
7402
7403
7404
7405
7406
7407
7408
7409
7410
7411
7412
7413
7414
7415
7416
7417
7418
7419
7420
7421
7422
7423
7424
7425
7426
7427
7428
7429
7430
7431
7432
7433
7434
7435
7436
7437
7438
7439
7440
7441
7442
7443
7444
7445
7446
7447
7448
7449
7450
7451
7452
7453
7454
7455
7456
7457
7458
7459
7460
7461
7462
7463
7464
7465
7466
7467
7468
7469
7470
7471
7472
7473
7474
7475
7476
7477
7478
7479
7480
7481
7482
7483
7484
7485
7486
7487
7488
7489
7490
7491
7492
7493
7494
7495
7496
7497
7498
7499
7500
7501
7502
7503
7504
7505
7506
7507
7508
7509
7510
7511
7512
7513
7514
7515
7516
7517
7518
7519
7520
7521
7522
7523
7524
7525
7526
7527
7528
7529
7530
7531
7532
7533
7534
7535
7536
7537
7538
7539
7540
7541
7542
7543
7544
7545
7546
7547
7548
7549
7550
7551
7552
7553
7554
7555
7556
7557
7558
7559
7560
7561
7562
7563
7564
7565
7566
7567
7568
7569
7570
7571
7572
7573
7574
7575
7576
7577
7578
7579
7580
7581
7582
7583
7584
7585
7586
7587
7588
7589
7590
7591
7592
7593
7594
7595
7596
7597
7598
7599
7600
| UnnamedSample_HQ_transcript/2096|m.1092 | UnnamedSample_HQ_transcript/2096 | Coverage 0.731 too low. | 07f7cada9ef6636c216f162623918abd | 1760 | Pfam | PF00520 | Ion transport protein | 859 | 1093 | 3.0E-16 | T | 22-09-2020 | IPR005821 | Ion transport domain |
| UnnamedSample_HQ_transcript/2096|m.1092 | UnnamedSample_HQ_transcript/2096 | Coverage 0.731 too low. | 07f7cada9ef6636c216f162623918abd | 1760 | Pfam | PF16519 | Tetramerisation domain of TRPM | 1184 | 1239 | 3.8E-19 | T | 22-09-2020 | IPR032415 | TRPM, tetramerisation domain |
| UnnamedSample_HQ_transcript/48266|m.13639 | UnnamedSample_HQ_transcript/48266 | Coverage 0.395 too low. | 7c2ee20068677f962d1392b52708a446 | 715 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 403 | 477 | 3.3E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/48266|m.13639 | UnnamedSample_HQ_transcript/48266 | Coverage 0.395 too low. | 7c2ee20068677f962d1392b52708a446 | 715 | Pfam | PF12738 | twin BRCT domain | 212 | 273 | 2.0E-13 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/48266|m.13639 | UnnamedSample_HQ_transcript/48266 | Coverage 0.395 too low. | 7c2ee20068677f962d1392b52708a446 | 715 | Pfam | PF12738 | twin BRCT domain | 116 | 175 | 4.0E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/48266|m.13639 | UnnamedSample_HQ_transcript/48266 | Coverage 0.395 too low. | 7c2ee20068677f962d1392b52708a446 | 715 | Pfam | PF16589 | BRCT domain, a BRCA1 C-terminus domain | 587 | 668 | 2.1E-8 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/75336|m.18910 | UnnamedSample_HQ_transcript/75336 | Coverage 0.612 too low. | b8b68458536e4fe430ad2e0227a5ffb0 | 294 | Pfam | PF07690 | Major Facilitator Superfamily | 41 | 232 | 1.8E-16 | T | 22-09-2020 | IPR011701 | Major facilitator superfamily |
| UnnamedSample_HQ_transcript/38396|m.11482 | UnnamedSample_HQ_transcript/38396 | Unmapped. | 36c6dab49cf761eb1dd8338ea5ba26be | 841 | Pfam | PF08762 | CRPV capsid protein like | 658 | 809 | 1.4E-9 | T | 22-09-2020 | IPR014872 | Dicistrovirus, capsid-polyprotein, C-terminal |
| UnnamedSample_HQ_transcript/108351|m.23622 | UnnamedSample_HQ_transcript/108351 | Coverage 0.514 too low. | 14f88962dc98339ff28161ac98a13be6 | 222 | Pfam | PF11901 | Protein of unknown function (DUF3421) | 136 | 211 | 1.8E-13 | T | 22-09-2020 | IPR024518 | Domain of unknown function DUF3421 |
| UnnamedSample_HQ_transcript/82560|m.20122 | UnnamedSample_HQ_transcript/82560 | Coverage 0.819 too low. | 515d5ceb1a92a6a6d9f749d7355f3dd1 | 424 | Pfam | PF14826 | FACT complex subunit SPT16 N-terminal lobe domain | 6 | 169 | 2.2E-46 | T | 22-09-2020 | IPR029148 | FACT complex subunit Spt16, N-terminal lobe domain |
| UnnamedSample_HQ_transcript/82560|m.20122 | UnnamedSample_HQ_transcript/82560 | Coverage 0.819 too low. | 515d5ceb1a92a6a6d9f749d7355f3dd1 | 424 | Pfam | PF00557 | Metallopeptidase family M24 | 184 | 414 | 3.2E-24 | T | 22-09-2020 | IPR000994 | Peptidase M24 |
| UnnamedSample_HQ_transcript/32086|m.9972 | UnnamedSample_HQ_transcript/32086 | Coverage 0.938 too low. | e7571ce2833ba10d68012e989747ecbe | 652 | Pfam | PF00856 | SET domain | 237 | 519 | 2.7E-12 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/34519|m.10610 | UnnamedSample_HQ_transcript/34519 | Coverage 0.951 too low. | e7571ce2833ba10d68012e989747ecbe | 652 | Pfam | PF00856 | SET domain | 237 | 519 | 2.7E-12 | T | 22-09-2020 | IPR001214 | SET domain |
| UnnamedSample_HQ_transcript/65304|m.17085 | UnnamedSample_HQ_transcript/65304 | Identity 0.665 too low. | 0bb1616cd73db01b0e73216fcd44756f | 194 | Pfam | PF13920 | Zinc finger, C3HC4 type (RING finger) | 138 | 187 | 7.6E-10 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/48673|m.13731 | UnnamedSample_HQ_transcript/48673 | Identity 0.703 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF00372 | Hemocyanin, copper containing domain | 153 | 268 | 4.5E-18 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/48673|m.13731 | UnnamedSample_HQ_transcript/48673 | Identity 0.703 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 61 | 142 | 1.9E-7 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/48673|m.13731 | UnnamedSample_HQ_transcript/48673 | Identity 0.703 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03723 | Hemocyanin, ig-like domain | 475 | 551 | 2.4E-13 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/48673|m.13731 | UnnamedSample_HQ_transcript/48673 | Identity 0.703 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03723 | Hemocyanin, ig-like domain | 349 | 472 | 2.3E-23 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/53857|m.14814 | UnnamedSample_HQ_transcript/53857 | Identity 0.653 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF00372 | Hemocyanin, copper containing domain | 153 | 268 | 4.5E-18 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/53857|m.14814 | UnnamedSample_HQ_transcript/53857 | Identity 0.653 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 61 | 142 | 1.9E-7 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/53857|m.14814 | UnnamedSample_HQ_transcript/53857 | Identity 0.653 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03723 | Hemocyanin, ig-like domain | 475 | 551 | 2.4E-13 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/53857|m.14814 | UnnamedSample_HQ_transcript/53857 | Identity 0.653 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03723 | Hemocyanin, ig-like domain | 349 | 472 | 2.3E-23 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/51131|m.14270 | UnnamedSample_HQ_transcript/51131 | Identity 0.698 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF00372 | Hemocyanin, copper containing domain | 153 | 268 | 4.5E-18 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/51131|m.14270 | UnnamedSample_HQ_transcript/51131 | Identity 0.698 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 61 | 142 | 1.9E-7 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/51131|m.14270 | UnnamedSample_HQ_transcript/51131 | Identity 0.698 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03723 | Hemocyanin, ig-like domain | 475 | 551 | 2.4E-13 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/51131|m.14270 | UnnamedSample_HQ_transcript/51131 | Identity 0.698 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03723 | Hemocyanin, ig-like domain | 349 | 472 | 2.3E-23 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/49382|m.13883 | UnnamedSample_HQ_transcript/49382 | Identity 0.688 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF00372 | Hemocyanin, copper containing domain | 153 | 268 | 4.5E-18 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/49382|m.13883 | UnnamedSample_HQ_transcript/49382 | Identity 0.688 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03722 | Hemocyanin, all-alpha domain | 61 | 142 | 1.9E-7 | T | 22-09-2020 | IPR005204 | Hemocyanin, N-terminal |
| UnnamedSample_HQ_transcript/49382|m.13883 | UnnamedSample_HQ_transcript/49382 | Identity 0.688 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03723 | Hemocyanin, ig-like domain | 475 | 551 | 2.4E-13 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/49382|m.13883 | UnnamedSample_HQ_transcript/49382 | Identity 0.688 too low. | 982f1eea412daaa04e4288844c3f00d4 | 570 | Pfam | PF03723 | Hemocyanin, ig-like domain | 349 | 472 | 2.3E-23 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/73432|m.18556 | UnnamedSample_HQ_transcript/73432 | Coverage 0.628 too low. | 83e2bd9b22f4e39ed925a02fce054625 | 535 | Pfam | PF01846 | FF domain | 319 | 374 | 3.7E-10 | T | 22-09-2020 | IPR002713 | FF domain |
| UnnamedSample_HQ_transcript/73432|m.18556 | UnnamedSample_HQ_transcript/73432 | Coverage 0.628 too low. | 83e2bd9b22f4e39ed925a02fce054625 | 535 | Pfam | PF01846 | FF domain | 104 | 153 | 1.8E-11 | T | 22-09-2020 | IPR002713 | FF domain |
| UnnamedSample_HQ_transcript/73432|m.18556 | UnnamedSample_HQ_transcript/73432 | Coverage 0.628 too low. | 83e2bd9b22f4e39ed925a02fce054625 | 535 | Pfam | PF01846 | FF domain | 463 | 504 | 2.0E-5 | T | 22-09-2020 | IPR002713 | FF domain |
| UnnamedSample_HQ_transcript/73432|m.18556 | UnnamedSample_HQ_transcript/73432 | Coverage 0.628 too low. | 83e2bd9b22f4e39ed925a02fce054625 | 535 | Pfam | PF01846 | FF domain | 241 | 294 | 2.0E-4 | T | 22-09-2020 | IPR002713 | FF domain |
| UnnamedSample_HQ_transcript/59221|m.15893 | UnnamedSample_HQ_transcript/59221 | Coverage 0.984 too low. | f3529c122588a7e037acc8982b163e8a | 547 | Pfam | PF00135 | Carboxylesterase family | 23 | 537 | 3.6E-126 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/53182|m.14678 | UnnamedSample_HQ_transcript/53182 | Coverage 0.974 too low. | f3529c122588a7e037acc8982b163e8a | 547 | Pfam | PF00135 | Carboxylesterase family | 23 | 537 | 3.6E-126 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/3372|m.1584 | UnnamedSample_HQ_transcript/3372 | Coverage 0.757 too low. | dcb13f4f01a6753b8b79e07f57a57c96 | 457 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 328 | 455 | 4.1E-29 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/3372|m.1584 | UnnamedSample_HQ_transcript/3372 | Coverage 0.757 too low. | dcb13f4f01a6753b8b79e07f57a57c96 | 457 | Pfam | PF00373 | FERM central domain | 59 | 179 | 1.8E-6 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/8711|m.3419 | UnnamedSample_HQ_transcript/8711 | Coverage 0.184 too low. | 93a8fbaaa51944b1f8a9a90a63dc8589 | 1093 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 965 | 1019 | 4.4E-10 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/79858|m.19685 | UnnamedSample_HQ_transcript/79858 | Coverage 0.261 too low. | 3d72189623767414f3f2848282573572 | 408 | Pfam | PF01337 | Barstar (barnase inhibitor) | 46 | 108 | 4.0E-6 | T | 22-09-2020 | IPR000468 | Barstar (barnase inhibitor) |
| UnnamedSample_HQ_transcript/47466|m.13456 | UnnamedSample_HQ_transcript/47466 | Coverage 0.499 too low. | 41a498b29b173d4ee74f496495999f18 | 106 | Pfam | PF01121 | Dephospho-CoA kinase | 3 | 80 | 1.1E-26 | T | 22-09-2020 | IPR001977 | Dephospho-CoA kinase |
| UnnamedSample_HQ_transcript/74975|m.18832 | UnnamedSample_HQ_transcript/74975 | Identity 0.905 too low. | 07d4ad3a36bc4fcb6fffda9c47445e32 | 167 | Pfam | PF00632 | HECT-domain (ubiquitin-transferase) | 3 | 146 | 1.8E-38 | T | 22-09-2020 | IPR000569 | HECT domain |
| UnnamedSample_HQ_transcript/85197|m.20525 | UnnamedSample_HQ_transcript/85197 | Coverage 0.983 too low. | 2b4a99a41a2c13f78eec621b2f38a7c8 | 412 | Pfam | PF07707 | BTB And C-terminal Kelch | 136 | 223 | 1.9E-8 | T | 22-09-2020 | IPR011705 | BTB/Kelch-associated |
| UnnamedSample_HQ_transcript/85197|m.20525 | UnnamedSample_HQ_transcript/85197 | Coverage 0.983 too low. | 2b4a99a41a2c13f78eec621b2f38a7c8 | 412 | Pfam | PF00651 | BTB/POZ domain | 21 | 126 | 1.5E-28 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/39637|m.11767 | UnnamedSample_HQ_transcript/39637 | Identity 0.947 too low. | 09f5ecd0101cf4502fab4ec27884f1da | 534 | Pfam | PF05485 | THAP domain | 99 | 163 | 5.3E-10 | T | 22-09-2020 | IPR006612 | THAP-type zinc finger |
| UnnamedSample_HQ_transcript/63792|m.16795 | UnnamedSample_HQ_transcript/63792 | Identity 0.849 too low. | 69aa79a5b0115c290edf8b1f209eff53 | 317 | Pfam | PF10488 | Phosphatase-1 catalytic subunit binding region | 220 | 309 | 1.7E-9 | T | 22-09-2020 | IPR019523 | Protein phosphatase 1, regulatory subunit 15A/B, C-terminal |
| UnnamedSample_HQ_transcript/16534|m.5867 | UnnamedSample_HQ_transcript/16534 | Coverage 0.905 too low. | e2fb2d9da6095cbab89a300763033a04 | 789 | Pfam | PF00307 | Calponin homology (CH) domain | 169 | 273 | 8.3E-27 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/16534|m.5867 | UnnamedSample_HQ_transcript/16534 | Coverage 0.905 too low. | e2fb2d9da6095cbab89a300763033a04 | 789 | Pfam | PF00307 | Calponin homology (CH) domain | 49 | 152 | 2.9E-20 | T | 22-09-2020 | IPR001715 | Calponin homology domain |
| UnnamedSample_HQ_transcript/16534|m.5867 | UnnamedSample_HQ_transcript/16534 | Coverage 0.905 too low. | e2fb2d9da6095cbab89a300763033a04 | 789 | Pfam | PF00435 | Spectrin repeat | 299 | 407 | 9.3E-13 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/16534|m.5867 | UnnamedSample_HQ_transcript/16534 | Coverage 0.905 too low. | e2fb2d9da6095cbab89a300763033a04 | 789 | Pfam | PF00435 | Spectrin repeat | 419 | 520 | 3.1E-17 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/16534|m.5867 | UnnamedSample_HQ_transcript/16534 | Coverage 0.905 too low. | e2fb2d9da6095cbab89a300763033a04 | 789 | Pfam | PF00435 | Spectrin repeat | 742 | 787 | 1.3E-9 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/16534|m.5867 | UnnamedSample_HQ_transcript/16534 | Coverage 0.905 too low. | e2fb2d9da6095cbab89a300763033a04 | 789 | Pfam | PF00435 | Spectrin repeat | 636 | 738 | 1.6E-25 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/16534|m.5867 | UnnamedSample_HQ_transcript/16534 | Coverage 0.905 too low. | e2fb2d9da6095cbab89a300763033a04 | 789 | Pfam | PF00435 | Spectrin repeat | 524 | 633 | 2.1E-14 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/3396|m.1590 | UnnamedSample_HQ_transcript/3396 | Coverage 0.062 too low. | 7b258dad9ed83ef34f2aea455fe3055f | 767 | Pfam | PF02149 | Kinase associated domain 1 | 725 | 767 | 3.2E-19 | T | 22-09-2020 | IPR001772 | Kinase associated domain 1 (KA1) |
| UnnamedSample_HQ_transcript/3396|m.1590 | UnnamedSample_HQ_transcript/3396 | Coverage 0.062 too low. | 7b258dad9ed83ef34f2aea455fe3055f | 767 | Pfam | PF00069 | Protein kinase domain | 51 | 305 | 4.6E-74 | T | 22-09-2020 | IPR000719 | Protein kinase domain |
| UnnamedSample_HQ_transcript/18855|m.6541 | UnnamedSample_HQ_transcript/18855 | Coverage 0.584 too low. | fefa81df9b73ad9ced2c5ffbeff3a909 | 993 | Pfam | PF00595 | PDZ domain | 22 | 90 | 9.7E-14 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/18855|m.6541 | UnnamedSample_HQ_transcript/18855 | Coverage 0.584 too low. | fefa81df9b73ad9ced2c5ffbeff3a909 | 993 | Pfam | PF00640 | Phosphotyrosine interaction domain (PTB/PID) | 189 | 294 | 1.2E-5 | T | 22-09-2020 | IPR006020 | PTB/PI domain |
| UnnamedSample_HQ_transcript/18855|m.6541 | UnnamedSample_HQ_transcript/18855 | Coverage 0.584 too low. | fefa81df9b73ad9ced2c5ffbeff3a909 | 993 | Pfam | PF00615 | Regulator of G protein signaling domain | 559 | 673 | 8.5E-29 | T | 22-09-2020 | IPR016137 | RGS domain |
| UnnamedSample_HQ_transcript/18855|m.6541 | UnnamedSample_HQ_transcript/18855 | Coverage 0.584 too low. | fefa81df9b73ad9ced2c5ffbeff3a909 | 993 | Pfam | PF02196 | Raf-like Ras-binding domain | 769 | 836 | 3.3E-13 | T | 22-09-2020 | IPR003116 | Raf-like Ras-binding |
| UnnamedSample_HQ_transcript/12475|m.4652 | UnnamedSample_HQ_transcript/12475 | Coverage 0.708 too low. | a093e5265b9d73015f1064a869fb501e | 855 | Pfam | PF00621 | RhoGEF domain | 414 | 595 | 5.5E-41 | T | 22-09-2020 | IPR000219 | Dbl homology (DH) domain |
| UnnamedSample_HQ_transcript/12475|m.4652 | UnnamedSample_HQ_transcript/12475 | Coverage 0.708 too low. | a093e5265b9d73015f1064a869fb501e | 855 | Pfam | PF12738 | twin BRCT domain | 143 | 205 | 4.5E-17 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/12475|m.4652 | UnnamedSample_HQ_transcript/12475 | Coverage 0.708 too low. | a093e5265b9d73015f1064a869fb501e | 855 | Pfam | PF00533 | BRCA1 C Terminus (BRCT) domain | 232 | 303 | 9.6E-6 | T | 22-09-2020 | IPR001357 | BRCT domain |
| UnnamedSample_HQ_transcript/67319|m.17459 | UnnamedSample_HQ_transcript/67319 | Coverage 0.601 too low. | f510f85f78dd3b7f22a1e2a38b732e96 | 516 | Pfam | PF13895 | Immunoglobulin domain | 37 | 121 | 3.7E-9 | T | 22-09-2020 | IPR007110 | Immunoglobulin-like domain |
| UnnamedSample_HQ_transcript/48172|m.13618 | UnnamedSample_HQ_transcript/48172 | Coverage 0.888 too low. | 9bbd5a2e4c2c698d46b21142b234efae | 292 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 3 | 280 | 4.2E-79 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/93386|m.21720 | UnnamedSample_HQ_transcript/93386 | Coverage 0.932 too low. | aa2dad0bdbf474c0a2c7c9c6b78fd909 | 371 | Pfam | PF17172 | Glutathione S-transferase N-terminal domain | 83 | 180 | 8.6E-29 | T | 22-09-2020 | IPR012336 | Thioredoxin-like fold |
| UnnamedSample_HQ_transcript/93386|m.21720 | UnnamedSample_HQ_transcript/93386 | Coverage 0.932 too low. | aa2dad0bdbf474c0a2c7c9c6b78fd909 | 371 | Pfam | PF17171 | Glutathione S-transferase, C-terminal domain | 235 | 300 | 2.8E-20 | T | 22-09-2020 | IPR033468 | Metaxin, glutathione S-transferase domain |
| UnnamedSample_HQ_transcript/46249|m.13195 | UnnamedSample_HQ_transcript/46249 | Coverage 0.142 too low. | da3ac5ef2042a7c4f26ac24e7e7b77c9 | 239 | Pfam | PF04750 | FAR-17a/AIG1-like protein | 14 | 218 | 3.8E-45 | T | 22-09-2020 | IPR006838 | FAR-17a/AIG1-like protein |
| UnnamedSample_HQ_transcript/35093|m.10734 | UnnamedSample_HQ_transcript/35093 | Unmapped. | efa5aacddbc476723e5274096454a011 | 406 | Pfam | PF13087 | AAA domain | 1 | 145 | 7.7E-19 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/69364|m.17822 | UnnamedSample_HQ_transcript/69364 | Unmapped. | 04225863cff91e4307dbccf5349e7685 | 266 | Pfam | PF00373 | FERM central domain | 3 | 133 | 2.4E-16 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/87|m.86 | UnnamedSample_HQ_transcript/87 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13086 | AAA domain | 401 | 471 | 8.6E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/87|m.86 | UnnamedSample_HQ_transcript/87 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13087 | AAA domain | 584 | 755 | 1.6E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/52|m.53 | UnnamedSample_HQ_transcript/52 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13086 | AAA domain | 401 | 471 | 8.6E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/52|m.53 | UnnamedSample_HQ_transcript/52 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13087 | AAA domain | 584 | 755 | 1.6E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/55|m.56 | UnnamedSample_HQ_transcript/55 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13086 | AAA domain | 401 | 471 | 8.6E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/55|m.56 | UnnamedSample_HQ_transcript/55 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13087 | AAA domain | 584 | 755 | 1.6E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/58|m.58 | UnnamedSample_HQ_transcript/58 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13086 | AAA domain | 401 | 471 | 8.6E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/58|m.58 | UnnamedSample_HQ_transcript/58 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13087 | AAA domain | 584 | 755 | 1.6E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/60|m.60 | UnnamedSample_HQ_transcript/60 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13086 | AAA domain | 401 | 471 | 8.6E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/60|m.60 | UnnamedSample_HQ_transcript/60 | Unmapped. | b3596044307719578b8afe1105418e0f | 1753 | Pfam | PF13087 | AAA domain | 584 | 755 | 1.6E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/118457|m.24720 | UnnamedSample_HQ_transcript/118457 | Coverage 0.912 too low. | 4cc64d4259fb474ef49136604c4d0e4c | 140 | Pfam | PF00754 | F5/8 type C domain | 19 | 126 | 4.4E-7 | T | 22-09-2020 | IPR000421 | Coagulation factor 5/8 C-terminal domain |
| UnnamedSample_HQ_transcript/32512|m.10087 | UnnamedSample_HQ_transcript/32512 | Coverage 0.673 too low. | 35579cdc0f4e6989d532738657f72c43 | 742 | Pfam | PF00226 | DnaJ domain | 679 | 719 | 6.2E-10 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/32512|m.10087 | UnnamedSample_HQ_transcript/32512 | Coverage 0.673 too low. | 35579cdc0f4e6989d532738657f72c43 | 742 | Pfam | PF00012 | Hsp70 protein | 59 | 666 | 3.9E-225 | T | 22-09-2020 | IPR013126 | Heat shock protein 70 family |
| UnnamedSample_HQ_transcript/24023|m.7954 | UnnamedSample_HQ_transcript/24023 | Coverage 0.066 too low. | ded0078d0077bcd4adfaf4cc3a1bce71 | 972 | Pfam | PF01595 | Cyclin M transmembrane N-terminal domain | 334 | 504 | 6.3E-36 | T | 22-09-2020 | IPR002550 | CNNM, transmembrane domain |
| UnnamedSample_HQ_transcript/2985|m.1438 | UnnamedSample_HQ_transcript/2985 | Coverage 0.299 too low. | ded0078d0077bcd4adfaf4cc3a1bce71 | 972 | Pfam | PF01595 | Cyclin M transmembrane N-terminal domain | 334 | 504 | 6.3E-36 | T | 22-09-2020 | IPR002550 | CNNM, transmembrane domain |
| UnnamedSample_HQ_transcript/94951|m.21950 | UnnamedSample_HQ_transcript/94951 | Coverage 0.362 too low. | e7f178b954e5ddf749c2012bc6ec5327 | 243 | Pfam | PF03250 | Tropomodulin | 48 | 187 | 5.1E-55 | T | 22-09-2020 | IPR004934 | Tropomodulin |
| UnnamedSample_HQ_transcript/111663|m.24039 | UnnamedSample_HQ_transcript/111663 | Coverage 0.889 too low. | 52e746ad9cb5a245db0c7afc2c6bbe91 | 270 | Pfam | PF00226 | DnaJ domain | 15 | 79 | 9.7E-21 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/1252|m.746 | UnnamedSample_HQ_transcript/1252 | Unmapped. | 920fd3e64a0209646edbe00bfcf19659 | 1198 | Pfam | PF13086 | AAA domain | 460 | 530 | 5.5E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/1252|m.746 | UnnamedSample_HQ_transcript/1252 | Unmapped. | 920fd3e64a0209646edbe00bfcf19659 | 1198 | Pfam | PF13087 | AAA domain | 643 | 814 | 9.6E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/11709|m.4396 | UnnamedSample_HQ_transcript/11709 | Identity 0.711 too low. | c1bde024c5a9219cf6b231ad43b7537f | 1260 | Pfam | PF00435 | Spectrin repeat | 125 | 223 | 8.0E-7 | T | 22-09-2020 | IPR002017 | Spectrin repeat |
| UnnamedSample_HQ_transcript/1959|m.1038 | UnnamedSample_HQ_transcript/1959 | Coverage 0.875 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF17787 | PH domain | 12 | 139 | 2.4E-44 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/1959|m.1038 | UnnamedSample_HQ_transcript/1959 | Coverage 0.875 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 8.3E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/1959|m.1038 | UnnamedSample_HQ_transcript/1959 | Coverage 0.875 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF08703 | PLC-beta C terminal | 1081 | 1241 | 5.6E-15 | T | 22-09-2020 | IPR014815 | Phospholipase C-beta, C-terminal domain |
| UnnamedSample_HQ_transcript/1959|m.1038 | UnnamedSample_HQ_transcript/1959 | Coverage 0.875 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF00387 | Phosphatidylinositol-specific phospholipase C, Y domain | 592 | 705 | 2.1E-39 | T | 22-09-2020 | IPR001711 | Phospholipase C, phosphatidylinositol-specific, Y domain |
| UnnamedSample_HQ_transcript/1959|m.1038 | UnnamedSample_HQ_transcript/1959 | Coverage 0.875 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 9.2E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/3263|m.1548 | UnnamedSample_HQ_transcript/3263 | Coverage 0.899 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF17787 | PH domain | 12 | 139 | 2.4E-44 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/3263|m.1548 | UnnamedSample_HQ_transcript/3263 | Coverage 0.899 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 8.3E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/3263|m.1548 | UnnamedSample_HQ_transcript/3263 | Coverage 0.899 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF08703 | PLC-beta C terminal | 1081 | 1241 | 5.6E-15 | T | 22-09-2020 | IPR014815 | Phospholipase C-beta, C-terminal domain |
| UnnamedSample_HQ_transcript/3263|m.1548 | UnnamedSample_HQ_transcript/3263 | Coverage 0.899 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF00387 | Phosphatidylinositol-specific phospholipase C, Y domain | 592 | 705 | 2.1E-39 | T | 22-09-2020 | IPR001711 | Phospholipase C, phosphatidylinositol-specific, Y domain |
| UnnamedSample_HQ_transcript/3263|m.1548 | UnnamedSample_HQ_transcript/3263 | Coverage 0.899 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 9.2E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/2313|m.1176 | UnnamedSample_HQ_transcript/2313 | Coverage 0.873 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF17787 | PH domain | 12 | 139 | 2.4E-44 | T | 22-09-2020 | IPR037862 | PLC-beta, PH domain |
| UnnamedSample_HQ_transcript/2313|m.1176 | UnnamedSample_HQ_transcript/2313 | Coverage 0.873 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF09279 | Phosphoinositide-specific phospholipase C, efhand-like | 212 | 308 | 8.3E-11 | T | 22-09-2020 | IPR015359 | Phosphoinositide-specific phospholipase C, EF-hand-like domain |
| UnnamedSample_HQ_transcript/2313|m.1176 | UnnamedSample_HQ_transcript/2313 | Coverage 0.873 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF08703 | PLC-beta C terminal | 1081 | 1241 | 5.6E-15 | T | 22-09-2020 | IPR014815 | Phospholipase C-beta, C-terminal domain |
| UnnamedSample_HQ_transcript/2313|m.1176 | UnnamedSample_HQ_transcript/2313 | Coverage 0.873 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF00387 | Phosphatidylinositol-specific phospholipase C, Y domain | 592 | 705 | 2.1E-39 | T | 22-09-2020 | IPR001711 | Phospholipase C, phosphatidylinositol-specific, Y domain |
| UnnamedSample_HQ_transcript/2313|m.1176 | UnnamedSample_HQ_transcript/2313 | Coverage 0.873 too low. | 302a627ef11404cc12df44709866582a | 1251 | Pfam | PF00388 | Phosphatidylinositol-specific phospholipase C, X domain | 319 | 466 | 9.2E-60 | T | 22-09-2020 | IPR000909 | Phosphatidylinositol-specific phospholipase C, X domain |
| UnnamedSample_HQ_transcript/47874|m.13553 | UnnamedSample_HQ_transcript/47874 | Coverage 0.579 too low. | d7c8ff91eaf85bfe7fc18cf1d378a2d6 | 598 | Pfam | PF09820 | Predicted AAA-ATPase | 2 | 326 | 2.3E-17 | T | 22-09-2020 | IPR018631 | AAA-ATPase-like domain |
| UnnamedSample_HQ_transcript/64014|m.16842 | UnnamedSample_HQ_transcript/64014 | Identity 0.714 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 255 | 340 | 2.2E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/64014|m.16842 | UnnamedSample_HQ_transcript/64014 | Identity 0.714 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 160 | 220 | 2.8E-8 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/92817|m.21635 | UnnamedSample_HQ_transcript/92817 | Coverage 0.814 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 255 | 340 | 2.2E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/92817|m.21635 | UnnamedSample_HQ_transcript/92817 | Coverage 0.814 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 160 | 220 | 2.8E-8 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/55359|m.15104 | UnnamedSample_HQ_transcript/55359 | Identity 0.733 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 255 | 340 | 2.2E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/55359|m.15104 | UnnamedSample_HQ_transcript/55359 | Identity 0.733 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 160 | 220 | 2.8E-8 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/57808|m.15618 | UnnamedSample_HQ_transcript/57808 | Identity 0.734 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 255 | 340 | 2.2E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/57808|m.15618 | UnnamedSample_HQ_transcript/57808 | Identity 0.734 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 160 | 220 | 2.8E-8 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/69092|m.17776 | UnnamedSample_HQ_transcript/69092 | Identity 0.706 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 255 | 340 | 2.2E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/69092|m.17776 | UnnamedSample_HQ_transcript/69092 | Identity 0.706 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 160 | 220 | 2.8E-8 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/73369|m.18536 | UnnamedSample_HQ_transcript/73369 | Identity 0.687 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 255 | 340 | 2.2E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/73369|m.18536 | UnnamedSample_HQ_transcript/73369 | Identity 0.687 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 160 | 220 | 2.8E-8 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/61051|m.16267 | UnnamedSample_HQ_transcript/61051 | Identity 0.722 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 255 | 340 | 2.2E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/61051|m.16267 | UnnamedSample_HQ_transcript/61051 | Identity 0.722 too low. | 6f363e0274f81817b33a55e6051e745b | 386 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 160 | 220 | 2.8E-8 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 587 | 609 | 0.0022 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 643 | 665 | 3.3E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 615 | 637 | 7.1E-5 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 136 | 158 | 1.6E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 164 | 186 | 7.4E-6 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 559 | 581 | 1.6E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 531 | 553 | 2.4E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 671 | 693 | 0.0047 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 387 | 409 | 2.7E-4 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 359 | 381 | 9.7E-7 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF00096 | Zinc finger, C2H2 type | 331 | 353 | 0.0011 | T | 22-09-2020 | IPR013087 | Zinc finger C2H2-type |
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF13912 | C2H2-type zinc finger | 504 | 526 | 0.024 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF13894 | C2H2-type zinc finger | 192 | 214 | 2.5E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/24585|m.8099 | UnnamedSample_HQ_transcript/24585 | Coverage 0.894 too low. | 652e724fc06bdbef54466c1e8920e83f | 801 | Pfam | PF13894 | C2H2-type zinc finger | 445 | 467 | 4.5E-4 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/112539|m.24143 | UnnamedSample_HQ_transcript/112539 | Coverage 0.283 too low. | 1bbb8edd7378ffc2e62db996214b8ec2 | 211 | Pfam | PF10501 | Ribosomal subunit 39S | 96 | 164 | 3.9E-6 | T | 22-09-2020 | IPR018305 | Ribosomal protein L50, mitochondria |
| UnnamedSample_HQ_transcript/116508|m.24537 | UnnamedSample_HQ_transcript/116508 | Coverage 0.175 too low. | 1bbb8edd7378ffc2e62db996214b8ec2 | 211 | Pfam | PF10501 | Ribosomal subunit 39S | 96 | 164 | 3.9E-6 | T | 22-09-2020 | IPR018305 | Ribosomal protein L50, mitochondria |
| UnnamedSample_HQ_transcript/57705|m.15596 | UnnamedSample_HQ_transcript/57705 | Coverage 0.978 too low. | 411b90817135a8bd3b0c2bac0c57505f | 595 | Pfam | PF00023 | Ankyrin repeat | 506 | 539 | 2.4E-4 | T | 22-09-2020 | IPR002110 | Ankyrin repeat |
| UnnamedSample_HQ_transcript/57705|m.15596 | UnnamedSample_HQ_transcript/57705 | Coverage 0.978 too low. | 411b90817135a8bd3b0c2bac0c57505f | 595 | Pfam | PF00023 | Ankyrin repeat | 462 | 505 | 0.0083 | T | 22-09-2020 | IPR002110 | Ankyrin repeat |
| UnnamedSample_HQ_transcript/57705|m.15596 | UnnamedSample_HQ_transcript/57705 | Coverage 0.978 too low. | 411b90817135a8bd3b0c2bac0c57505f | 595 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 118 | 180 | 3.5E-13 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/57705|m.15596 | UnnamedSample_HQ_transcript/57705 | Coverage 0.978 too low. | 411b90817135a8bd3b0c2bac0c57505f | 595 | Pfam | PF12796 | Ankyrin repeats (3 copies) | 10 | 82 | 2.1E-10 | T | 22-09-2020 | IPR020683 | Ankyrin repeat-containing domain |
| UnnamedSample_HQ_transcript/79129|m.19572 | UnnamedSample_HQ_transcript/79129 | Coverage 0.833 too low. | deb746ef5277c1a1d8c5fc96e7fa8f6f | 435 | Pfam | PF00651 | BTB/POZ domain | 23 | 116 | 1.4E-24 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/111108|m.23976 | UnnamedSample_HQ_transcript/111108 | Coverage 0.984 too low. | 1b86dad3411c0939518b0d3336185ead | 198 | Pfam | PF06984 | Mitochondrial 39-S ribosomal protein L47 (MRP-L47) | 38 | 123 | 1.1E-35 | T | 22-09-2020 | IPR010729 | Ribosomal protein L47, mitochondrial |
| UnnamedSample_HQ_transcript/46258|m.13198 | UnnamedSample_HQ_transcript/46258 | Coverage 0.938 too low. | f4b43e96e6a17f3f41d8dd78c0e1c576 | 315 | Pfam | PF00201 | UDP-glucoronosyl and UDP-glucosyl transferase | 48 | 293 | 5.2E-9 | T | 22-09-2020 | IPR002213 | UDP-glucuronosyl/UDP-glucosyltransferase |
| UnnamedSample_HQ_transcript/119820|m.24832 | UnnamedSample_HQ_transcript/119820 | Coverage 0.974 too low. | 02e5887354c8153b527730825e6ac997 | 162 | Pfam | PF00756 | Putative esterase | 3 | 155 | 1.0E-25 | T | 22-09-2020 | IPR000801 | Putative esterase |
| UnnamedSample_HQ_transcript/52912|m.14627 | UnnamedSample_HQ_transcript/52912 | Coverage 0.265 too low. | e785fb08c06c82f069f58119fd8a81bc | 589 | Pfam | PF03022 | Major royal jelly protein | 202 | 275 | 5.5E-25 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/52912|m.14627 | UnnamedSample_HQ_transcript/52912 | Coverage 0.265 too low. | e785fb08c06c82f069f58119fd8a81bc | 589 | Pfam | PF03022 | Major royal jelly protein | 329 | 565 | 3.0E-63 | T | 22-09-2020 | IPR017996 | Major royal jelly protein/protein yellow |
| UnnamedSample_HQ_transcript/37826|m.11352 | UnnamedSample_HQ_transcript/37826 | Identity 0.626 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/38138|m.11432 | UnnamedSample_HQ_transcript/38138 | Identity 0.630 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/39663|m.11777 | UnnamedSample_HQ_transcript/39663 | Coverage 0.965 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/41508|m.12159 | UnnamedSample_HQ_transcript/41508 | Identity 0.612 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/32519|m.10088 | UnnamedSample_HQ_transcript/32519 | Identity 0.651 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/29075|m.9247 | UnnamedSample_HQ_transcript/29075 | Identity 0.672 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/29652|m.9391 | UnnamedSample_HQ_transcript/29652 | Identity 0.661 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/26503|m.8607 | UnnamedSample_HQ_transcript/26503 | Identity 0.676 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/33505|m.10337 | UnnamedSample_HQ_transcript/33505 | Identity 0.646 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/37204|m.11213 | UnnamedSample_HQ_transcript/37204 | Identity 0.641 too low. | f4292aa89769a1784db6e4f8d43745f6 | 738 | Pfam | PF03098 | Animal haem peroxidase | 162 | 704 | 1.1E-177 | T | 22-09-2020 | IPR019791 | Haem peroxidase, animal-type |
| UnnamedSample_HQ_transcript/115107|m.24406 | UnnamedSample_HQ_transcript/115107 | Coverage 0.970 too low. | 5427e77f107dfe53032c410e4c741d33 | 165 | Pfam | PF01981 | Peptidyl-tRNA hydrolase PTH2 | 51 | 165 | 2.8E-34 | T | 22-09-2020 | IPR002833 | Peptidyl-tRNA hydrolase, PTH2 |
| UnnamedSample_HQ_transcript/27094|m.8743 | UnnamedSample_HQ_transcript/27094 | Coverage 0.034 too low. | ccd98c8cada40e65337d235c2265a994 | 896 | Pfam | PF01571 | Aminomethyltransferase folate-binding domain | 457 | 764 | 8.1E-51 | T | 22-09-2020 | IPR006222 | Aminomethyltransferase, folate-binding domain |
| UnnamedSample_HQ_transcript/27094|m.8743 | UnnamedSample_HQ_transcript/27094 | Coverage 0.034 too low. | ccd98c8cada40e65337d235c2265a994 | 896 | Pfam | PF08669 | Glycine cleavage T-protein C-terminal barrel domain | 788 | 873 | 7.2E-17 | T | 22-09-2020 | IPR013977 | Glycine cleavage T-protein, C-terminal barrel domain |
| UnnamedSample_HQ_transcript/27094|m.8743 | UnnamedSample_HQ_transcript/27094 | Coverage 0.034 too low. | ccd98c8cada40e65337d235c2265a994 | 896 | Pfam | PF16350 | FAD dependent oxidoreductase central domain | 398 | 452 | 2.2E-18 | T | 22-09-2020 | IPR032503 | FAD dependent oxidoreductase, central domain |
| UnnamedSample_HQ_transcript/27094|m.8743 | UnnamedSample_HQ_transcript/27094 | Coverage 0.034 too low. | ccd98c8cada40e65337d235c2265a994 | 896 | Pfam | PF01266 | FAD dependent oxidoreductase | 38 | 393 | 7.3E-65 | T | 22-09-2020 | IPR006076 | FAD dependent oxidoreductase |
| UnnamedSample_HQ_transcript/30665|m.9637 | UnnamedSample_HQ_transcript/30665 | Coverage 0.035 too low. | ccd98c8cada40e65337d235c2265a994 | 896 | Pfam | PF01571 | Aminomethyltransferase folate-binding domain | 457 | 764 | 8.1E-51 | T | 22-09-2020 | IPR006222 | Aminomethyltransferase, folate-binding domain |
| UnnamedSample_HQ_transcript/30665|m.9637 | UnnamedSample_HQ_transcript/30665 | Coverage 0.035 too low. | ccd98c8cada40e65337d235c2265a994 | 896 | Pfam | PF08669 | Glycine cleavage T-protein C-terminal barrel domain | 788 | 873 | 7.2E-17 | T | 22-09-2020 | IPR013977 | Glycine cleavage T-protein, C-terminal barrel domain |
| UnnamedSample_HQ_transcript/30665|m.9637 | UnnamedSample_HQ_transcript/30665 | Coverage 0.035 too low. | ccd98c8cada40e65337d235c2265a994 | 896 | Pfam | PF16350 | FAD dependent oxidoreductase central domain | 398 | 452 | 2.2E-18 | T | 22-09-2020 | IPR032503 | FAD dependent oxidoreductase, central domain |
| UnnamedSample_HQ_transcript/30665|m.9637 | UnnamedSample_HQ_transcript/30665 | Coverage 0.035 too low. | ccd98c8cada40e65337d235c2265a994 | 896 | Pfam | PF01266 | FAD dependent oxidoreductase | 38 | 393 | 7.3E-65 | T | 22-09-2020 | IPR006076 | FAD dependent oxidoreductase |
| UnnamedSample_HQ_transcript/40635|m.11990 | UnnamedSample_HQ_transcript/40635 | Coverage 0.906 too low. | 1526c25a954b1eb6b63f730ad4faca81 | 282 | Pfam | PF00617 | RasGEF domain | 24 | 143 | 5.1E-37 | T | 22-09-2020 | IPR001895 | Ras guanine-nucleotide exchange factors catalytic domain |
| UnnamedSample_HQ_transcript/17190|m.6066 | UnnamedSample_HQ_transcript/17190 | Coverage 0.679 too low. | 727674f3df99854cbcf4923b8fac9404 | 515 | Pfam | PF00400 | WD domain, G-beta repeat | 68 | 102 | 0.12 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/17190|m.6066 | UnnamedSample_HQ_transcript/17190 | Coverage 0.679 too low. | 727674f3df99854cbcf4923b8fac9404 | 515 | Pfam | PF00400 | WD domain, G-beta repeat | 141 | 178 | 5.2E-5 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/18515|m.6450 | UnnamedSample_HQ_transcript/18515 | Coverage 0.674 too low. | 9eb1ba86d641404fa43db7a67b216e67 | 578 | Pfam | PF05679 | Chondroitin N-acetylgalactosaminyltransferase | 19 | 566 | 2.0E-179 | T | 22-09-2020 | IPR008428 | Chondroitin N-acetylgalactosaminyltransferase |
| UnnamedSample_HQ_transcript/100543|m.22711 | UnnamedSample_HQ_transcript/100543 | Identity 0.946 too low. | df9f1b76284d799b0664c16ac671b77d | 101 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 5 | 62 | 7.9E-13 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/17685|m.6218 | UnnamedSample_HQ_transcript/17685 | Coverage 0.186 too low. | 8cf11614f148debbd092649eee5ccad1 | 760 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 246 | 475 | 7.6E-84 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/24491|m.8064 | UnnamedSample_HQ_transcript/24491 | Coverage 0.093 too low. | 8cf11614f148debbd092649eee5ccad1 | 760 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 246 | 475 | 7.6E-84 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/18253|m.6381 | UnnamedSample_HQ_transcript/18253 | Coverage 0.181 too low. | 8cf11614f148debbd092649eee5ccad1 | 760 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 246 | 475 | 7.6E-84 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/14948|m.5387 | UnnamedSample_HQ_transcript/14948 | Coverage 0.233 too low. | 8cf11614f148debbd092649eee5ccad1 | 760 | Pfam | PF00233 | 3'5'-cyclic nucleotide phosphodiesterase | 246 | 475 | 7.6E-84 | T | 22-09-2020 | IPR002073 | 3'5'-cyclic nucleotide phosphodiesterase, catalytic domain |
| UnnamedSample_HQ_transcript/65266|m.17073 | UnnamedSample_HQ_transcript/65266 | Coverage 0.988 too low. | 13ec56258d0ca7066f926a43678a9c32 | 198 | Pfam | PF15477 | Small acidic protein family | 116 | 191 | 9.1E-18 | T | 22-09-2020 | IPR028124 | Small acidic protein-like domain |
| UnnamedSample_HQ_transcript/61680|m.16385 | UnnamedSample_HQ_transcript/61680 | Coverage 0.987 too low. | 13ec56258d0ca7066f926a43678a9c32 | 198 | Pfam | PF15477 | Small acidic protein family | 116 | 191 | 9.1E-18 | T | 22-09-2020 | IPR028124 | Small acidic protein-like domain |
| UnnamedSample_HQ_transcript/33601|m.10362 | UnnamedSample_HQ_transcript/33601 | Coverage 0.371 too low. | 908891659916f4c150acac19a6e2ca91 | 814 | Pfam | PF04389 | Peptidase family M28 | 78 | 271 | 2.4E-29 | T | 22-09-2020 | IPR007484 | Peptidase M28 |
| UnnamedSample_HQ_transcript/61708|m.16390 | UnnamedSample_HQ_transcript/61708 | Coverage 0.197 too low. | b51fa788db425c56007b851e70223999 | 499 | Pfam | PF00083 | Sugar (and other) transporter | 39 | 492 | 4.8E-121 | T | 22-09-2020 | IPR005828 | Major facilitator, sugar transporter-like |
| UnnamedSample_HQ_transcript/75660|m.18963 | UnnamedSample_HQ_transcript/75660 | Coverage 0.976 too low. | b1c888237540dedb2111eb29b7177385 | 415 | Pfam | PF02958 | Ecdysteroid kinase | 48 | 317 | 5.5E-52 | T | 22-09-2020 | IPR004119 | Ecdysteroid kinase-like |
| UnnamedSample_HQ_transcript/8319|m.3296 | UnnamedSample_HQ_transcript/8319 | Identity 0.735 too low. | 286121979c3805d562afe6894f33a98b | 833 | Pfam | PF00041 | Fibronectin type III domain | 621 | 705 | 7.8E-10 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/8319|m.3296 | UnnamedSample_HQ_transcript/8319 | Identity 0.735 too low. | 286121979c3805d562afe6894f33a98b | 833 | Pfam | PF00041 | Fibronectin type III domain | 504 | 587 | 7.8E-9 | T | 22-09-2020 | IPR003961 | Fibronectin type III |
| UnnamedSample_HQ_transcript/8319|m.3296 | UnnamedSample_HQ_transcript/8319 | Identity 0.735 too low. | 286121979c3805d562afe6894f33a98b | 833 | Pfam | PF07679 | Immunoglobulin I-set domain | 309 | 402 | 3.6E-6 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8319|m.3296 | UnnamedSample_HQ_transcript/8319 | Identity 0.735 too low. | 286121979c3805d562afe6894f33a98b | 833 | Pfam | PF07679 | Immunoglobulin I-set domain | 127 | 208 | 1.1E-14 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/8319|m.3296 | UnnamedSample_HQ_transcript/8319 | Identity 0.735 too low. | 286121979c3805d562afe6894f33a98b | 833 | Pfam | PF13927 | Immunoglobulin domain | 421 | 485 | 2.5E-9 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8319|m.3296 | UnnamedSample_HQ_transcript/8319 | Identity 0.735 too low. | 286121979c3805d562afe6894f33a98b | 833 | Pfam | PF13927 | Immunoglobulin domain | 22 | 107 | 1.8E-7 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8319|m.3296 | UnnamedSample_HQ_transcript/8319 | Identity 0.735 too low. | 286121979c3805d562afe6894f33a98b | 833 | Pfam | PF13927 | Immunoglobulin domain | 216 | 286 | 2.9E-14 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/11650|m.4377 | UnnamedSample_HQ_transcript/11650 | Coverage 0.134 too low. | b710f9125c5dac9911bb1bc3f1f09028 | 605 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 134 | 196 | 1.7E-11 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/11650|m.4377 | UnnamedSample_HQ_transcript/11650 | Coverage 0.134 too low. | b710f9125c5dac9911bb1bc3f1f09028 | 605 | Pfam | PF00313 | 'Cold-shock' DNA-binding domain | 284 | 343 | 3.3E-11 | T | 22-09-2020 | IPR002059 | Cold-shock protein, DNA-binding |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 672 | 716 | 2.1E-8 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 625 | 669 | 1.8E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 464 | 511 | 3.4E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 572 | 622 | 2.0E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 719 | 758 | 3.5E-5 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 430 | 454 | 1.2E-4 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 178 | 226 | 1.5E-9 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 130 | 174 | 1.1E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 514 | 569 | 1.0E-7 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00053 | Laminin EGF domain | 39 | 87 | 2.9E-10 | T | 22-09-2020 | IPR002049 | Laminin EGF domain |
| UnnamedSample_HQ_transcript/504|m.371 | UnnamedSample_HQ_transcript/504 | Coverage 0.787 too low. | 3d4aec69bfe4be905b3787090d23fa42 | 1052 | Pfam | PF00052 | Laminin B (Domain IV) | 294 | 429 | 4.5E-23 | T | 22-09-2020 | IPR000034 | Laminin IV |
| UnnamedSample_HQ_transcript/34501|m.10605 | UnnamedSample_HQ_transcript/34501 | Coverage 0.814 too low. | 2ae92209ea1fa02d04d30103bf4ef38b | 360 | Pfam | PF03166 | MH2 domain | 56 | 224 | 1.4E-32 | T | 22-09-2020 | IPR001132 | SMAD domain, Dwarfin-type |
| UnnamedSample_HQ_transcript/61516|m.16353 | UnnamedSample_HQ_transcript/61516 | Unmapped. | 81a59328301e84959d5313cf0fc442d4 | 635 | Pfam | PF00910 | RNA helicase | 208 | 316 | 1.6E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
